Merck
CN
  • Conformational change in transfer RNA is an early indicator of acute cellular damage.

Conformational change in transfer RNA is an early indicator of acute cellular damage.

Journal of the American Society of Nephrology : JASN (2014-05-17)
Eikan Mishima, Chisako Inoue, Daisuke Saigusa, Ryusuke Inoue, Koki Ito, Yusuke Suzuki, Daisuke Jinno, Yuri Tsukui, Yosuke Akamatsu, Masatake Araki, Kimi Araki, Ritsuko Shimizu, Haruka Shinke, Takehiro Suzuki, Yoichi Takeuchi, Hisato Shima, Yasutoshi Akiyama, Takafumi Toyohara, Chitose Suzuki, Yoshikatu Saiki, Teiji Tominaga, Shigehito Miyagi, Naoki Kawagisihi, Tomoyoshi Soga, Takayoshi Ohkubo, Kenichi Yamamura, Yutaka Imai, Satohiro Masuda, Venkata Sabbisetti, Takaharu Ichimura, David B Mount, Joseph V Bonventre, Sadayoshi Ito, Yoshihisa Tomioka, Kunihiko Itoh, Takaaki Abe
摘要

Tissue damage by oxidative stress is a key pathogenic mechanism in various diseases, including AKI and CKD. Thus, early detection of oxidative tissue damage is important. Using a tRNA-specific modified nucleoside 1-methyladenosine (m1A) antibody, we show that oxidative stress induces a direct conformational change in tRNA structure that promotes subsequent tRNA fragmentation and occurs much earlier than DNA damage. In various models of tissue damage (ischemic reperfusion, toxic injury, and irradiation), the levels of circulating tRNA derivatives increased rapidly. In humans, the levels of circulating tRNA derivatives also increased under conditions of acute renal ischemia, even before levels of other known tissue damage markers increased. Notably, the level of circulating free m1A correlated with mortality in the general population (n=1033) over a mean follow-up of 6.7 years. Compared with healthy controls, patients with CKD had higher levels of circulating free m1A, which were reduced by treatment with pitavastatin (2 mg/d; n=29). Therefore, tRNA damage reflects early oxidative stress damage, and detection of tRNA damage may be a useful tool for identifying organ damage and forming a clinical prognosis.

材料
货号
品牌
产品描述

Sigma-Aldrich
核糖核酸,转移 来源于大肠杆菌, Type XX, Strain W, lyophilized powder
Sigma-Aldrich
腺苷, ≥99%
Sigma-Aldrich
核糖核酸,转移 来源于面包酵母(酿酒酵母), Type X-SA, lyophilized powder
Sigma-Aldrich
核糖核酸,转移 来源于面包酵母(酿酒酵母), buffered aqueous solution
Sigma-Aldrich
腺苷, suitable for cell culture, BioReagent
Sigma-Aldrich
核糖核酸,转移 来源于面包酵母(酿酒酵母), buffered aqueous solution
Supelco
腺苷, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ribonucleic acid, transfer from bovine liver, Type XI, lyophilized powder
Sigma-Aldrich
腺苷
Sigma-Aldrich
核糖核酸,转移 来源于小麦胚芽, Type V, 15-19 units/mg solid
腺苷, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
腺苷, Vetec, reagent grade, 98%